133 related articles for article (PubMed ID: 38151827)
21. Discordant Mismatch Repair Protein Immunoreactivity in Lynch Syndrome-Associated Neoplasms: A Recommendation for Screening Synchronous/Metachronous Neoplasms.
Roth RM; Haraldsdottir S; Hampel H; Arnold CA; Frankel WL
Am J Clin Pathol; 2016 Jul; 146(1):50-6. PubMed ID: 27357288
[TBL] [Abstract][Full Text] [Related]
22. Pilot study of gene mutations associated with Lynch syndrome in Slovak patients with breast cancer.
Krasničanová L; Saade R; Priščáková P; Gbelcová H; Kaľavská K; Karaba M; Benca J; Mego M; Repiská V
Klin Onkol; 2023; 36(2):130-134. PubMed ID: 37072247
[TBL] [Abstract][Full Text] [Related]
23. Mismatch repair gone awry: Management of Lynch syndrome.
Zhang T; Boswell EL; McCall SJ; Hsu DS
Crit Rev Oncol Hematol; 2015 Mar; 93(3):170-9. PubMed ID: 25459670
[TBL] [Abstract][Full Text] [Related]
24. A Durable Response to Pembrolizumab in a Patient with Uterine Serous Carcinoma and Lynch Syndrome due to the MSH6 Germline Mutation.
T Danley K; Schmitz K; Ghai R; Sclamberg JS; Buckingham LE; Burgess K; Kuzel TM; Usha L
Oncologist; 2021 Oct; 26(10):811-817. PubMed ID: 34018286
[TBL] [Abstract][Full Text] [Related]
25. Lynch syndrome in colorectal cancer patients.
Giráldez MD; Castellví-Bel S; Balaguer F; Gonzalo V; Ocaña T; Castells A
Expert Rev Anticancer Ther; 2008 Apr; 8(4):573-83. PubMed ID: 18402524
[TBL] [Abstract][Full Text] [Related]
26. Lynch syndrome: further defining the pediatric spectrum.
Self C; Suttman A; Wolfe Schneider K; Hoffman L
Cancer Genet; 2021 Nov; 258-259():37-40. PubMed ID: 34343771
[TBL] [Abstract][Full Text] [Related]
27. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome.
Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ
Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668
[TBL] [Abstract][Full Text] [Related]
28. A practical screening strategy for Lynch syndrome and Lynch syndrome mimics in colorectal cancer.
Yao ZG; Lv BB; Jing HY; Su WJ; Li JM; Fan H; Zhao MQ; Qin YJ; Sun XC
J Cancer Res Ther; 2021 Jul; 17(3):790-796. PubMed ID: 34269315
[TBL] [Abstract][Full Text] [Related]
29. Case report: A colorectal cancer patient with microsatellite instability-high and
Zhang Q; Hu J; Zhang Y; Li L; Wang T; Qian X
Front Immunol; 2022; 13():953421. PubMed ID: 35990637
[TBL] [Abstract][Full Text] [Related]
30. Detection of DNA mismatch repair deficient crypts in random colonoscopic biopsies identifies Lynch syndrome patients.
Brand RE; Dudley B; Karloski E; Das R; Fuhrer K; Pai RK; Pai RK
Fam Cancer; 2020 Apr; 19(2):169-175. PubMed ID: 31997046
[TBL] [Abstract][Full Text] [Related]
31. Missed opportunities: Genetic counseling and testing among an ethnically diverse cohort of women with endometrial cancer.
Lee J; Gubernick LR; Brodsky AL; Fehniger JE; Levine DA; Gerber D; Asgari SA; Cantor A; Martineau JT; Ginsburg OM; Smith JA; Pothuri B
Gynecol Oncol; 2018 Oct; 151(1):153-158. PubMed ID: 30077346
[TBL] [Abstract][Full Text] [Related]
32. Utility of immunohistochemistry for mismatch repair proteins on colorectal polyps in the familial cancer clinic.
Dow E; Buchanan DD; Winship IM
Intern Med J; 2018 Nov; 48(11):1325-1330. PubMed ID: 29717530
[TBL] [Abstract][Full Text] [Related]
33. Challenges in the diagnosis and management of Lynch Syndrome in an Indigenous family living in a remote West Australian community.
Schofield L; Goldblatt J; Iacopetta B
Rural Remote Health; 2011; 11(4):1836. PubMed ID: 22188021
[TBL] [Abstract][Full Text] [Related]
34. An Analysis of Clinical, Surgical, Pathological and Molecular Characteristics of Endometrial Cancer According to Mismatch Repair Status. A Multidisciplinary Approach.
Dondi G; Coluccelli S; De Leo A; Ferrari S; Gruppioni E; Bovicelli A; Godino L; Coadă CA; Morganti AG; Giordano A; Santini D; Ceccarelli C; Turchetti D; De Iaco P; Perrone AM
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003368
[TBL] [Abstract][Full Text] [Related]
35. Undifferentiated and Dedifferentiated Metastatic Melanomas Masquerading as Soft Tissue Sarcomas: Mutational Signature Analysis and Immunotherapy Response.
Kasago IS; Chatila WK; Lezcano CM; Febres-Aldana CA; Schultz N; Vanderbilt C; Dogan S; Bartlett EK; D'Angelo SP; Tap WD; Singer S; Ladanyi M; Shoushtari AN; Busam KJ; Hameed M
Mod Pathol; 2023 Aug; 36(8):100165. PubMed ID: 36990277
[TBL] [Abstract][Full Text] [Related]
36. Familial Burden and Other Clinical Factors Associated With Various Types of Cancer in Individuals With Lynch Syndrome.
Biller LH; Horiguchi M; Uno H; Ukaegbu C; Syngal S; Yurgelun MB
Gastroenterology; 2021 Jul; 161(1):143-150.e4. PubMed ID: 33794268
[TBL] [Abstract][Full Text] [Related]
37. [A family with clustered Lynch syndrome: a case report].
Zhu X; Cai L; Xiao J
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Aug; 42(8):1263-1266. PubMed ID: 36073228
[TBL] [Abstract][Full Text] [Related]
38. Mismatch repair protein immunohistochemistry: a useful population screening strategy for Lynch syndrome.
Musulén E; Sanz C; Muñoz-Mármol AM; Ariza A
Hum Pathol; 2014 Jul; 45(7):1388-96. PubMed ID: 24768606
[TBL] [Abstract][Full Text] [Related]
39. Mismatch repair from Lynch syndrome to immunotherapy: A brief primer for cytopathologists.
Kerr SE
Cancer Cytopathol; 2020 Aug; 128(8):515-517. PubMed ID: 32196978
[No Abstract] [Full Text] [Related]
40. Frameshift mutational target gene analysis identifies similarities and differences in constitutional mismatch repair-deficiency and Lynch syndrome.
Maletzki C; Huehns M; Bauer I; Ripperger T; Mork MM; Vilar E; Klöcking S; Zettl H; Prall F; Linnebacher M
Mol Carcinog; 2017 Jul; 56(7):1753-1764. PubMed ID: 28218421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
